特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
762887

世界の遺伝子検査市場調査と予測

Global Genetic Testing Market Research and Forecast, 2018-2023

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円
世界の遺伝子検査市場調査と予測
出版日: 2018年11月06日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の遺伝子検査市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査サマリー

第2章 市場概要と考察

  • 定義
  • アナリストの考察と現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 法規制

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • 技術別市場
    • 分子検査
    • 生化学検査
    • その他の検査
  • タイプ別市場
    • 出生前・新生児遺伝子検査
    • 予防検査
    • 移植前検査
    • 診断検査
    • キャリア検査
    • 法医学検査
  • 疾患別市場
    • アルツハイマー
    • 嚢胞性線維症
    • ファンコニ貧血
    • デュシェンヌ型筋ジストロフィー
    • 鎌状赤血球貧血
    • その他

第5章 競合環境

  • 主な戦略分析
  • 主要企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 企業のプロファイル

図表

List of Tables

  • TABLE # 1 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL MOLECULAR TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL BIOCHEMICAL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL OTHER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL PRENATAL AND NEWBORN TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL PREDICTIVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL PRE-IMPLANTATION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL CARRIER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL FORENSIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 12 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
  • TABLE # 13 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 14 GLOBAL ALZHEIMER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 15 GLOBAL CYSTIC FIBROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 16 GLOBAL FANCONI ANEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 17 GLOBAL DUCHENE'S MUSCULAR DYSTROPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 18 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 19 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 20 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 21 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 22 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 23 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
  • TABLE # 24 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 25 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 26 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 27 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
  • TABLE # 28 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 29 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 30 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 31 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
  • TABLE # 32 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 33 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 34 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL GENETIC TESTING MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (IN %)
  • FIGURE # 2 GLOBAL GENETIC TESTING MARKET SHARE BY TYPE, 2017 VS 2023 (IN %)
  • FIGURE # 3 GLOBAL GENETIC TESTING MARKET SHARE BY DISEASE TYPE, 2017 VS 2023 (IN %)
  • FIGURE # 4 GLOBAL GENETIC TESTING MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
  • FIGURE # 5 US GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 UK GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 FRANCE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 GERMANY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 ITALY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 SPAIN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 ROE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 INDIA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 CHINA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 JAPAN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 REST OF ASIA-PACIFIC GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 REST OF THE WORLD GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018411

The global genetic testing market is expected to grow at a modest CAGR during 2018-2023. Genetic testing is a medical test that is used for the identification of changes in chromosomes or in genes. A suspected genetic condition can be confirmed or ruled out by the results of genetic testing. It enables the determination of the possibility of a person, developing or passing a genetic disorder. The rising prevalence of the genetic disorder is one of the major factors that is augmenting the genetic testing market. According to the Genesis foundation for children, in 2017, 1 in every 33 children in the US is born with an intellectual or genetic disorder. It is estimated that about 120,000 babies in the US are affected each year. All birth disorders cannot be prevented. However, there is an increased chance of having a healthy baby by genetic testing. Genetic testing provides early detection of any genetic disorder enabling it to be ruled out.

The factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, Alzheimer's and so on. Apart from this, initiatives taken by the government such as the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative is significantly driving the market growth. EGAPP was launched by the Centers for Disease Control and Prevention in 2004. This initiative was aimed at the establishment and testing of an evidence-based process for the evaluation of genetic tests and other applications of genomic technology. In addition, increasing awareness of the people regarding genomics is accelerating the growth of the market.

Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America is growing at a very significant rate. The reason for this is that the presence of key industry players increased genetic diseases and supportive government initiatives. Moreover, the Asia-Pacific region is anticipated to be the fastest developing region during the forecast period. Factors such as increasing awareness among people and the growing focus of key industry players on emerging countries in the region are driving the growth of the market.

The companies contributing to the growth of global genetic testing market are Abbott Laboratories Inc., Applied Biosystems Inc., AutoGenomics Inc., BioRad Laboratories Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp. and so on. Majority of key players are acquiring or entering into strategic alliance with other key players from the market to gain a competitive edge over others and enhance their presence.

Research methodology

The market study of the global genetic testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • An authentic database such as the National Society of Genetic Counselors, American Medical Association (AMA) and so on.
  • Company websites and their product/ services catalog.

The report is intended for biotechnology and life science companies, research institutes and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, growth opportunity in the market and product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

THE REPORT COVERS

  • Comprehensive research methodology of the global genetic testing market.
  • This report also includes a detailed and extensive market overview with analyst insights & key market trends.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global genetic testing market.
  • Insights about market determinants which are stimulating the global genetic testing market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations
    • 2.3.1. United States
    • 2.3.2. European Union
    • 2.3.3. China
    • 2.3.4. India
    • 2.3.5. Rest of the World

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Rise in Genetic Diseases
    • 3.1.2. Rising demand for Early Disease Detection and Prevention
    • 3.1.3. Increasing Application of Genetic Testing in Oncology
    • 3.1.4. Supportive Government Initiatives
  • 3.2. Restraints
    • 3.2.1. Strict Regulatory Policies
    • 3.2.2. Issues Associated with Genetic Testing
    • 3.2.3. High Cost of Genetic Testing
  • 3.3. Opportunities
    • 3.3.1. Technological Advancement
    • 3.3.2. Growing Demand for Personalized Medicine
    • 3.3.3. Investment in Research And Development

4. Market Segmentation

  • 4.1. Global Genetic Testing Market by Technology
    • 4.1.1. Molecular Testing
    • 4.1.2. Biochemical Testing
    • 4.1.3. Other Testing
  • 4.2. Global Genetic Testing Market by Type
    • 4.2.1. Prenatal and New-Born Genetic Testing
    • 4.2.2. Predictive Testing
    • 4.2.3. Pre-Implantation Testing
    • 4.2.4. Diagnostic Testing
    • 4.2.5. Carrier Testing
    • 4.2.6. Forensic Testing
  • 4.3. Global Genetic Testing Market by Disease
    • 4.3.1. Cancer
    • 4.3.2. Alzheimer
    • 4.3.3. Cystic Fibrosis
    • 4.3.4. Fanconi Anaemia
    • 4.3.5. Ducheme's Muscular Dystrophy
    • 4.3.6. Sickle Cell Anaemia
    • 4.3.7. Others

5. Competitive Landscape

  • 5.1. Key Company Analysis
  • 5.2. Key Strategy Analysis

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. United Kingdom
    • 6.2.2. France
    • 6.2.3. Germany
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. 23Andme, Inc.
  • 7.3. AutoGenomics, Inc.
  • 7.4. Biocartis SA
  • 7.5. Biomerieux SA
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. Cepheid, Inc.
  • 7.8. EKF Diagnostics
  • 7.9. Elitech Group
  • 7.10. Genentech, Inc.
  • 7.11. Genomictree Inc.
  • 7.12. Illumina, Inc.
  • 7.13. IntegraGen S.A.
  • 7.14. Interpace Diagnostics, LLC
  • 7.15. Luminex Corporation
  • 7.16. MedGenome, Inc.
  • 7.17. Myriad Genetics, Inc.
  • 7.18. PerkinElmer, Inc.
  • 7.19. Qiagen N.V.
  • 7.20. Quest Diagnostics, Inc.
  • 7.21. Roche Molecular Systems, Inc.
  • 7.22. Sequenom
  • 7.23. Thermo Fisher Scientific, Inc.
  • 7.24. Takara Bio, Inc.
  • 7.25. Transgenomic, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.